Impact of oral oncolytic initiation on medication adherence for pre-existing comorbid chronic conditions.

Ankur A DashputreKatie S GatwoodJillian SchmidtJustin Gatwood

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)

Initiation of oral oncolytics may negatively impact adherence to oral therapies for chronic comorbid conditions, necessitating the need for medication management strategies to help patients adhere to their entire medication regimen.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
healthcare
chronic kidney disease
adverse drug
emergency department
metabolic syndrome
skeletal muscle
patient reported
drug induced
glycemic control
weight loss
electronic health record